Skip to content
healthcare.dev

Letrozole

NDC 59651-180, Letrozole, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
59651-180
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211717
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-180 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LETROZOLE2.5 mg/1

Pharmacologic classes

Aromatase Inhibitor [EPC]; Aromatase Inhibitors [MoA]

Package NDCNDC-11Package
59651-180-305965101803030 TABLET, FILM COATED in 1 BOTTLE (59651-180-30)
59651-180-905965101809090 TABLET, FILM COATED in 1 BOTTLE (59651-180-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ff7325d2-3383-4ff9-a187-9350e3538640
  • NADAC price for package 59651018030

    GET /v1/drugs/nadac/59651018030

Use it

Look up 59651-180 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-180 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.